Marroof Ahmed S, Hassan Meaad K
Department of Pediatrics, Al-Zubair general Hospital, Basrah Health Directorate, Basrah, IRQ.
Department of Pediatrics, College of Medicine, University of Basrah, Basrah, IRQ.
Cureus. 2024 Apr 14;16(4):e58277. doi: 10.7759/cureus.58277. eCollection 2024 Apr.
Background Patients with sickle cell disease (SCD) often present in the Emergency Department (ED) with acute and debilitating pain and other SCD-related complications. Objectives The objective is to analyze the causes of ED visits of pediatric patients with SCD, assess the burden of ED admission due to SCD in relation to other pediatric diseases, the treatment given, and the outcomes. Methods A prospective analytical study was conducted on children and adolescents with SCD, 1-14 years old who had been admitted to the ED at Basrah Maternity and Children Hospital over a six-month period. Patient's sociodemographic and clinical data, drug history, length of ED stay, complications, outcome, and readmissions were recorded. Results A total of 422 patients with SCD were admitted to ED during the study period representing 4.10% of the total admitted cases; 276(65.40%) of them were recruited in this study, and their mean age was 7.84 ±3.47 years. The main cause for ED admission was pain (73.91%), followed by infection (10.14%) and hemolytic crisis (6.15%). The mean duration of stay at ED was 6.11±1.87 hours. All admitted SCD patients had received analgesia; non-steroidal anti-inflammatory drugs (NSAIDs) were the commonest (80.4%), followed by acetaminophen (39.5%), and opioid narcotic (18.5%). Readmission within 30-days was reported in 82(29.71%) patients and was associated with the number of ED visits/last year (B=0.151, P=0.023), length of stay at ED (B=0.140, P=0.034) and severe disease (B=0.253, P<0.001). Conclusions Acute painful episodes were the main cause of ED admission. Although most patients with pain did receive NSAIDs, only a small percentage of them did receive opioids. About one-third of patients have been readmitted within 30 days, and readmission was associated with the number of ED visits/last year, disease severity, and length of ED stay. These findings can help in establishing local guidelines for managing such patients in the ED especially pain management.
镰状细胞病(SCD)患者常因急性剧烈疼痛和其他与SCD相关的并发症前往急诊科(ED)就诊。目的:分析小儿SCD患者急诊就诊的原因,评估SCD导致的急诊住院负担与其他儿科疾病的关系、所接受的治疗及治疗结果。方法:对巴士拉妇幼医院6个月内收治的1 - 14岁SCD儿童和青少年进行前瞻性分析研究。记录患者的社会人口学和临床数据、用药史、急诊留观时间、并发症、治疗结果及再次入院情况。结果:研究期间共有422例SCD患者入住急诊,占总入院病例的4.10%;其中276例(65.40%)纳入本研究,平均年龄为7.84±3.47岁。急诊入院的主要原因是疼痛(73.91%),其次是感染(10.14%)和溶血危象(6.15%)。急诊平均留观时间为6.11±1.87小时。所有入院的SCD患者均接受了镇痛治疗;非甾体类抗炎药(NSAIDs)使用最为常见(80.4%),其次是对乙酰氨基酚(39.5%)和阿片类麻醉药(18.5%)。82例(29.71%)患者在30天内再次入院,且与急诊就诊次数/去年(B = 0.151,P = 0.023)、急诊留观时间(B = 0.140,P = 0.034)和重症疾病(B = 0.253,P < 0.001)相关。结论:急性疼痛发作是急诊入院的主要原因。虽然大多数疼痛患者确实接受了NSAIDs治疗,但只有一小部分患者接受了阿片类药物治疗。约三分之一的患者在30天内再次入院,且再次入院与去年急诊就诊次数、疾病严重程度和急诊留观时间相关。这些研究结果有助于制定当地急诊科此类患者的管理指南,尤其是疼痛管理指南。